亚临床甲状腺功能减退症与心血管疾病血栓形成相关性研究进展
Research Progress on the Correlation between Subclinical Hypothyroidism and Thrombosis of Cardiovascular Disease
DOI: 10.12677/ACM.2022.1291177, PDF,    科研立项经费支持
作者: 侯丽媛：济宁医学院临床医学院，山东 济宁；国 伟*：济宁市第一人民医院，山东 济宁
关键词: 亚临床甲状腺减退症；血栓；冠心病；心血管疾病；相关性；Subclinical Hypothyroidism； Thrombosis； Coronary Heart Disease； Cardiovascular Disease； Relevance
摘要: 甲状腺功能与机体能量代谢和生长发育密切相关，并与多种心血管活动紧密相关。近年来的研究表明，甲状腺功能障碍患者的外周血抗凝指标存在明显异常，而凝血性能的改变与心血管疾病的发生发展有一定的相关性。亚临床甲状腺功能减退症(subclinical hypothyroidism, SCH)是介于临床甲减和正常人之间的过渡状态，目前对于不同程度SCH患者与心血管疾病血栓形成的相关性研究存在争议。本文就亚临床甲减与血栓形成的机制、冠心病危险因素的相关性及预后等最新进展做一综述。
Abstract: Thyroid function is closely related to the body’s energy metabolism, growth and development, and is closely related to a variety of cardiovascular activities. Studies in recent years have shown that there are obvious abnormalities in peripheral blood anticoagulation indexes in patients with thy-roid dysfunction, and the changes in coagulation properties are related to the occurrence and de-velopment of cardiovascular diseases. Subclinical hypothyroidism (SCH) is a transitional state be-tween clinical hypothyroidism and normal individuals. At present, there is controversy about the relationship between patients with different degrees of SCH and thrombosis of cardiovascular dis-ease. This article reviews the latest progress in the mechanism of subclinical hypothyroidism and thrombosis, and the correlation between coronary heart disease risk factors and prognosis.
文章引用：侯丽媛, 国伟. 亚临床甲状腺功能减退症与心血管疾病血栓形成相关性研究进展[J]. 临床医学进展, 2022, 12(9): 8170-8177. https://doi.org/10.12677/ACM.2022.1291177

参考文献

[1] Floriani, C., Gencer, B., Collet, T.H. and Rodondi, N. (2018) Subclinical Thyroid Dysfunction and Cardiovascular Dis-eases: 2016 Update. European Heart Journal, 39, 503-507. [Google Scholar] [CrossRef] [PubMed]
[2] Jabbar, A., Pingitore, A., Pearce, S.H., Zaman, A., Iervasi, G. and Razvi, S. (2017) Thyroid Hormones and Cardiovascular Dis-ease. Nature Reviews Cardiology, 14, 39-55. [Google Scholar] [CrossRef] [PubMed]
[3] Moon, S., Kim, M.J., Yu, J.M., Yoo, H.J. and Park, Y.J. (2018) Subclinical Hypothyroidism and the Risk of Cardiovascular Disease and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies. Thyroid, 28, 1101-1110. [Google Scholar] [CrossRef] [PubMed]
[4] Manolis, A.A., Manolis, T.A., Melita, H. and Manolis, A.S. (2020) Subclinical Thyroid Dysfunction and Cardiovascular Consequences: An Alarming Wake-Up Call? Trends in Cardio-vascular Medicine, 30, 57-69. [Google Scholar] [CrossRef] [PubMed]
[5] Bano, A., Chaker, L., Mattace-Raso, F.U.S., et al. (2017) Thyroid Function and the Risk of Atherosclerotic Cardiovascular Morbidity and Mortality: The Rotterdam Study. Circulation Re-search, 121, 1392-1400. [Google Scholar] [CrossRef] 
[6] 杨娜, 梁文龙, 谢会娟. 亚临床甲减对冠心病患者脂质代谢、斑块稳定性及内皮功能损伤的影响[J]. 实验与检验医学, 2021, 39(3): 547-551.
[7] Spartalis, M., Spar-talis, E., Athanasiou, A., et al. (2020) The Role of the Endothelium in Premature Atherosclerosis: Molecular Mechanisms. Current Medicinal Chemistry, 27, 1041-1051. [Google Scholar] [CrossRef] [PubMed]
[8] Gong, N., Gao, C., Chen, X., Fang, Y. and Tian, L. (2019) Endothelial Function in Patients with Subclinical Hypothyroidism: A Meta-Analysis. Hormone and Metabolic Research, 51, 691-702. [Google Scholar] [CrossRef] [PubMed]
[9] Molinaro, S., Iervasi, G., Lorenzoni, V., et al. (2012) Persistence of Mortality Risk in Patients with Acute Cardiac Diseases and Mild Thyroid Dysfunction. The Amer-ican Journal of the Medical Sciences, 343, 65-70. [Google Scholar] [CrossRef] 
[10] Marongiu, F., Cauli, C. and Mariotti, S. (2004) Thyroid, Hemostasis and Thrombosis. Journal of Endocrinological Investigation, 27, 1065-1071. [Google Scholar] [CrossRef] 
[11] Squizzato, A., Romualdi, E., Buller, H.R. and Gerdes, V.E. (2007) Clin-ical Review: Thyroid Dysfunction and Effects on Coagulation and Fibrinolysis: A Systematic Review. The Journal of Clinical Endocrinology & Metabolism, 92, 2415-2420. [Google Scholar] [CrossRef] [PubMed]
[12] Cai, P., Peng, Y., Chen, Y., Wang, Y. and Wang, X. (2021) Blood Pressure Characteristics of Subclinical Hypothyroidism: An Observa-tion Study Combined with Office Blood Pressure and 24-h Ambulatory Blood Pressure. Journal of Hypertension, 39, 453-460. [Google Scholar] [CrossRef] 
[13] Lu, M., Yang, C.B., Gao, L. and Zhao, J.J. (2015) Mechanism of Subclinical Hypothyroidism Accelerating Endothelial Dysfunction (Review). Experimental and Therapeu-tic Medicine, 9, 3-10. [Google Scholar] [CrossRef] [PubMed]
[14] Taddei, S., Caraccio, N., Virdis, A., et al. (2003) Impaired Endothelium-Dependent Vasodilatation in Subclinical Hypothyroidism: Beneficial Effect of Levothyroxine Therapy. The Journal of Clinical Endocrinology & Metabolism, 88, 3731-3737. [Google Scholar] [CrossRef] [PubMed]
[15] 胡静涛, 张小丽. CAHD合并亚临床甲状腺功能减退症30例临床分析[J]. 转化医学电子杂志, 2014, 1(2): 51-52.
[16] 薛乐, 闫晓琴, 王秋艳. 大量输血患者凝血功能和纤溶系统指标变化及临床意义[J]. 陕西医学杂志, 2020, 49(10): 1343-1346.
[17] 张卫星. 亚临床甲状腺功能减退与2型糖尿病大血管并发症的相关性研究[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2019.
[18] 郑歌, 马子坤, 林博, 韩冉, 寿好长. 不同程度亚临床甲状腺功能减退症患者凝血和纤溶相关指标变化及其临床意义[J]. 新乡医学院学报, 2021, 38(7): 653-656.
[19] 阮梦瑶, 赵国安. 纤维蛋白原与心血管疾病的相关性研究进展[J]. 新乡医学院学报, 2020, 37(5): 494-497.
[20] Muller, B., Tsakiris, D.A., Roth, C.B., Guglielmetti, M., Staub, J.J. and Marbet, G.A. (2001) Haemostatic Profile in Hypothyroidism as Potential Risk Factor for Vascular or Thrombotic Disease. European Journal of Clinical Investigation, 31, 131-137. [Google Scholar] [CrossRef] [PubMed]
[21] Rodondi, N., den Elzcn, W.P., Baucr, D.C., et al. (2010) Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality. JAMA, 304, 1365-1374. [Google Scholar] [CrossRef] [PubMed]
[22] 殷小红, 马卫国, 谢传庆, 王芬芬, 李亚. 凝血相关指标与亚临床甲状腺功能减退症患者病情的关系[J]. 血栓与止血学, 2020, 26(5): 804-805.
[23] 王哲, 郭瑾, 秦纲, 吕吉元. 平均血小板体积与心血管疾病[J]. 中华临床医师杂志(电子版), 2017, 11(9): 1578-1581.
[24] Coceani, M., Molinaro, S., Scalese, M., et al. (2011) Thyroid Hormone, Amiodarone Therapy, and Prognosis in Left Ventricular Systolic Dysfunction. Journal of Endocrinological Investigation, 34, e144-e148. [Google Scholar] [CrossRef] 
[25] 王旭东, 李哲, 贾永平. 亚临床甲状腺功能减退症与冠心病的相关关系研究[J]. 中西医结合心脑血管病杂志, 2016, 14(1): 55-57.
[26] 马冰, 孙玉芹. 冠心病合并亚临床甲状腺功能减退症相关因素分析[J]. 吉林医药学院学报, 2020, 41(2): 89-92.
[27] 国杨, 徐予, 唐熠达, 等. 冠心病合并房颤患者的甲状腺激素水平变化及临床意义[J]. 中国循环杂志, 2013, 5(1): 133-134.
[28] 杨丽萍, 赵谷天, 陈宗宁, 茶丽珠, 赵渊. 冠心病合并房颤患者的甲状腺激素水平变化及其机制探讨[J]. 西部医学, 2016, 28(10): 1386-1388, 1392.
[29] Tu, Y.P., Lei, M.J., Wu, X.H., et al. (2011) Influence of Subclinical Hypothyroidism on Blood Nitric Oxide and C-Reactive Protein in Patients with Coronary Heart Disease. Clinical Focus, 26, 491-493.
[30] Ordookhani, A. and Burman, K.D. (2017) Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders. International Journal of En-docrinology and Metabolism, 15, e42649. [Google Scholar] [CrossRef] [PubMed]
[31] 高芳, 张云娜, 赵乃蕊, 李翠柳, 杨馨鑫. 不同程度亚临床甲状腺功能减退症患者止凝血相关指标变化的研究[J]. 检验医学, 2018, 33(2): 110-114.
[32] Caracerio, N., Virdis, A., et al. (2000) Subclinical Hypothy Roil Patients Are Characterized by Endotheli-al Dysfunction Caused by an Impairment in the Largninenitric Oxide Pathway (Abstract). Endocrine Journal, 47, 225.
[33] 权晓慧, 王聪霞, 张春艳, 等. 冠心病合并亚临床甲减患者冠状动脉狭窄程度与内皮功能损伤的相关性[J]. 西安交通大学学报(医学版), 2018, 39(4): 471-474.
[34] 李彦博. 冠心病合并糖尿病患者血小板参数与炎症反应的相关性研究[D]: [博士学位论文]. 武汉: 武汉大学, 2012.
[35] Veeranna, V., Zalawadiya, S.K., Niraj, A., et al. (2011) Homocysteine and Reclassification of Cardiovascular Disease Risk. Journal of the American College of Cardiology, 58, 1025-1033. [Google Scholar] [CrossRef] [PubMed]
[36] Turhan, S., Sezer, S., Erden, G., et al. (2008) Plasma Homocysteine Concentrations and Serum Lipid Profile as Atherosclerotic Risk Factors in Subclinical Hypothyroidism. Annals of Saudi Medicine, 28, 96-101. [Google Scholar] [CrossRef] [PubMed]
[37] 许昕. 血清胱抑素C及同型半胱氨酸与急性缺血性脑卒中颅内血管病变的关系[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2018.
[38] 王文斌, 郭奇奇, 李奇, 成宜舜, 尹克金, 栾丽芹. 亚临床甲状腺功能减退患者促甲状腺素水平与缺血性脑血管病危险因素的相关性[J]. 中国临床研究, 2021, 34(7): 934-936+941. [Google Scholar] [CrossRef] 
[39] 申慧敏, 赵艳琳, 王乐. 亚临床甲减合并血脂异常患者血清甲状腺激素、HCY水平变化及临床意义[J]. 中外医学研究, 2021, 19(6): 20-22. [Google Scholar] [CrossRef] 
[40] 钟善传, 安江宏, 陈金超, 等. 亚临床甲状腺功能减退症患者血小板参数与凝血4项水平及其临床意义[J]. 检验医学与临床, 2014, 11(19): 2690-2691, 2695.
[41] 黄绵清, 薛冀苏, 幸思忠, 谢昌辉. 亚临床甲状腺功能减退患者同型半胱氨酸水平与冠状动脉粥样硬化的关系[J]. 中国老年学杂志, 2006(4): 455-456.
[42] Delitala, A.P., Fanciulli, G., Maioli, M. and Delitala, G. (2017) Subclinical Hy-pothyroidism, Lipid Metabolism and CVD. European Journal of Internal Medicine, 38, 17-24. [Google Scholar] [CrossRef] [PubMed]
[43] Toda, A., Hara, S., Tsuji, H. and Arase, Y. (2020) Subclinical Hy-pothyroidism Is Associated with Albuminuria in Japanese Nondiabetic Subjects. Endocrine, 68, 592-598. [Google Scholar] [CrossRef] [PubMed]
[44] Yao, K., Zhao, T., Zeng, L., et al. (2018) Non-Invasive Markers of Cardiovascular Risk in Patients with Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis of 27 Case Control Studies. Scientific Reports, 8, Article No. 4579. [Google Scholar] [CrossRef] [PubMed]
[45] Zhang, T., Xia, Y., Han, T., Zhang, H. and Baker, P.N. (2020) Five Serum Fatty Acids Are Associated with Subclinical Hypothyroidism in a Chinese Pregnant Population. Scientific Reports, 10, Article No. 6743. [Google Scholar] [CrossRef] [PubMed]
[46] 尹冬梅, 许敏, 田惠. 亚临床甲状腺功能减退症患者血脂及超敏C反应蛋白变化分析[J]. 中国医师进修杂志, 2014, 37(19): 19-21.
[47] 熊小玲, 杜鸣, 邵迎新. 冠心病合并甲状腺功能异常患者血脂水平的临床分析[J]. 现代中西医结合杂志, 2015, 24(1): 83-84.
[48] Rhee, C.M., Curhan, G.C., Alexander, E.K., Bhan, I. and Brunelli, S.M. (2013) Subclinical Hypothyroidism and Survival: The Effects of Heart Failure and Race. The Journal of Clinical Endocrinology & Metabolism, 98, 2326-2336. [Google Scholar] [CrossRef] [PubMed]
[49] Chin, K.Y., Ima-Nirwana, S., Mohamed, I., Aminuddin, A., Johari, M.H. and Ngah, W.Z. (2014) The Relationships between Thyroid Hormones and Thyroid-Stimulating Hormone with Lipid Profile in Euthyroid Men. International Journal of Medical Sciences, 11, 349-355. [Google Scholar] [CrossRef] [PubMed]
[50] Liu, F.H., Hwang, J., Kuo, C.F., et al. (2018) Subclinical Hypothyroidism and Metabolic Risk Factors Association: A Health Examination-Based Study in Northern Taiwan. Biomedical Journal, 41, 52-58. [Google Scholar] [CrossRef] [PubMed]
[51] 李晓盼. 冠心病合并亚临床甲减患者TSH水平与血脂的相关性[D]: [硕士学位论文]. 承德: 承德医学院, 2020.[CrossRef] 
[52] 熊鹏锋. 亚临床甲减与冠心病患者脉搏波传导速度C反应蛋白及血小板活化之间关系的研究[D]: [硕士学位论文]. 南昌: 南昌大学, 2012.
[53] Udovcic, M., Pena, R.H., Patham, B., Tabatabai, L. and Kansara, A. (2017) Hypothyroidism and the Heart. Methodist DeBakey Cardiovas-cular Journal, 13, 55-59. [Google Scholar] [CrossRef] [PubMed]
[54] Seo, S.M., Koh, Y.S., Park, H.J., et al. (2018) Thyroid Stimulating Hormone Elevation as a Predictor of Long-Term Mortality in Patients with Acute Myocardial Infarc-tion. Clinical Cardiology, 41, 1367-1373. [Google Scholar] [CrossRef] [PubMed]
[55] Inoue, K., Ritz, B., Brent, G.A., Ebrahimi, R., Rhee, C.M. and Leung, A.M. (2020) Association of Subclinical Hypothyroidism and Cardiovascular Disease with Mortality. JAMA Network Open, 3, e1920745. [Google Scholar] [CrossRef] [PubMed]
[56] 曾祥川, 李林河, 蔺鹏阳, 等. 亚临床甲状腺功能减退与急性冠脉综合征患者预后的关系[J]. 中国心血管病杂志, 2020, 25(5): 437-441.
[57] Zhou, X.Z., Shi, R., Wang, J., et al. (2021) Characteristics of Coronary Artery Disease in Patients with Subclinical Hypothyroidism: Evalua-tion Using Coronary Artery Computed Tomography Angiography. BMC Cardiovascular Disorders, 21, Article No. 303. [Google Scholar] [CrossRef] [PubMed]
[58] Rosario, P.W.S. and Calsolari, M.R. (2020) Subclinical Hypo-thyroidism with TSH > 7 mIU/L and ≤ 10 mIU/L and Coronary Artery Disease. Hormone and Metabolic Research, 52, 85-88. [Google Scholar] [CrossRef] [PubMed]
[59] Hyland, K.A., Arnold, A.M., Lee, J.S. and Cappola, A.R. (2013) Persistent Subclinical Hypothyroidism and Cardiovascular Risk in the Elderly: The Cardiovascular Health Study. The Journal of Clinical Endocrinology & Metabolism, 98, 533-540. [Google Scholar] [CrossRef] [PubMed]
[60] LeGrys, V.A., Funk, M.J., Lorenz, C.E., et al. (2013) Subclinical Hypothyroidism and Risk for Incident Myocardial Infarction among Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism, 98, 2308-2317. [Google Scholar] [CrossRef] [PubMed]
[61] Moutzouri, E., Lyko, C., Feller, M., et al. (2021) Subclinical Thyroid Function and Cardiovascular Events in Patients with Atrial Fibrillation. European Journal of Endocrinology, 185, 375-385. [Google Scholar] [CrossRef] 

为你推荐